Back to the main directory
Press Release
- Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System by GlobeNewsWire
- Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- Flexsteel Industries, Inc. to Announce Fourth Quarter 2023 Results on August 21 by BusinessWire
- Kyocera to Construct New Development Center at Shiga Yasu Campus in Japan by BusinessWire
- COMMUNIQUE DU 7 AOUT 2023 DEPOT D’UN PROJET DE NOTE EN RÉPONSE DE LA SOCIETE BIOCORP DANS LE CADRE DE L’OFFRE PUBLIQUE D’ACHAT SIMPLIFIEE INITIEE PAR NOVO NORDISK REGION EUROPE A/S VISANT LES ACTIONS DE LA SOCIÉTÉ BIOCORP PRODUCTION by BusinessWire
- Blink Charging CEO, Brendan Jones, to Discuss Blink’s Strategy and Recent Company Results at J.P. Morgan 2023 Auto Conference by GlobeNewsWire
- Subsea 7 S.A. Treasury Shares by GlobeNewsWire
- Lisata Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14 After Market Trading and to Host Conference Call on Tuesday, August 15 at 8:30 a.m. Eastern Time by GlobeNewsWire
- Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators by BusinessWire
- Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET by GlobeNewsWire
- The Real Good Food Company to Report Second Quarter 2023 Financial Results on Friday, August 11 at 9:30 a.m. Eastern Time by GlobeNewsWire
- Star Equity Holdings to Release Second Quarter 2023 Financial Results on August 11th by GlobeNewsWire
- Perma-Fix Joint Venture Awarded $40 Million, 5-Year USACE Contract for Environmental Remediation at the Niagara Falls Storage Site by GlobeNewsWire
- Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms by GlobeNewsWire
- Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting by GlobeNewsWire
- GRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal Models by GlobeNewsWire
- National Indemnity Company Selects Guidewire Cloud to Transform Policy, Underwriting, and Billing IT Operations by BusinessWire
- BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Pekka Jalovaara by GlobeNewsWire
- BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Jarmo Halonen by GlobeNewsWire
- BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Ahti Paananen by GlobeNewsWire
- HashiCorp to announce second quarter fiscal year 2024 financial results Aug. 31, 2023 by GlobeNewsWire
- Micron Launches Memory Expansion Module Portfolio to Accelerate CXL 2.0 Adoption by GlobeNewsWire
- 180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake by GlobeNewsWire
- FRIEDMAN INDUSTRIES, INCORPORATED LAUNCHES NEW COMPANY WEBSITE by GlobeNewsWire